C4 Therapeutics to Participate in the 8th Annual Evercore Healthcare Conference

Rhea-AI Summary

C4 Therapeutics (Nasdaq: CCCC) management will participate in a fireside chat at the 8th Annual Evercore Healthcare Conference in Coral Gables, Florida, on December 3, 2025 at 3:25 pm ET. A live webcast of the presentation will be available on the company’s Investors website and an archived replay will be accessible for approximately 90 days after the event.

This presentation provides an opportunity for investors to hear management discuss clinical programs and corporate strategy.

News Market Reaction – CCCC

+0.81%

18 alerts

+0.81% News Effect

+3.4% Peak in 5 hr 6 min

+$2M Valuation Impact

$263M Market Cap

1.1x Rel. Volume

On the day this news was published, CCCC gained 0.81%, reflecting a mild positive market reaction. Argus tracked a peak move of +3.4% during that session. Our momentum scanner triggered 18 alerts that day, indicating notable trading interest and price volatility. This price movement added approximately $2M to the company's valuation, bringing the market cap to $263M at that time.

Data tracked by StockTitan Argus on the day of publication.

WATERTOWN, Mass., Nov. 25, 2025 (GLOBE NEWSWIRE) -- C4 Therapeutics, Inc. (C4T) (Nasdaq: CCCC), a clinical-stage biopharmaceutical company dedicated to advancing targeted protein degradation science, today announced that C4T management will participate in a fireside chat at the 8^th Annual Evercore Healthcare Conference taking place from December 2 - 4, 2025 in Coral Gables, Florida.

Fireside Chat Details:
Event: 8^th Annual Evercore Healthcare Conference
Date/Time: Wednesday, December 3^rd, 2025 at 3:25 pm ET

A live webcast will be available on the Investors section of the company’s website at www.c4therapeutics.com. An archived replay of the webcast will be available for approximately 90 days following the live event.

About C4 Therapeutics

C4 Therapeutics (C4T) (Nasdaq: CCCC) is a clinical-stage biopharmaceutical company dedicated to delivering on the promise of targeted protein degradation science to create a new generation of medicines that transforms patients’ lives. C4T is progressing targeted oncology programs through clinical studies and leveraging its TORPEDO^® platform to efficiently design and optimize small-molecule medicines to address difficult-to-treat diseases. C4T’s degrader medicines are designed to harness the body’s natural protein recycling system to rapidly degrade disease-causing proteins, offering the potential to overcome drug resistance, drug undruggable targets and improve patient outcomes. For more information, please visit www.c4therapeutics.com.

Contacts:

Investors:
Courtney Solberg
Associate Director, Investor Relations
CSolberg@c4therapeutics.com

Media:
Loraine Spreen
Senior Director, Corporate Communications & Patient Advocacy
LSpreen@c4therapeutics.com

FAQ

When will C4 Therapeutics (CCCC) present at the Evercore Healthcare Conference?

C4 Therapeutics will present on December 3, 2025 at 3:25 pm ET.

How can investors watch the C4 Therapeutics (CCCC) fireside chat webcast?

A live webcast will be available on the company’s Investors website.

Will the C4 Therapeutics (CCCC) webcast be available after the live event?

Yes, an archived replay will be available for approximately 90 days following the live event.

What topics will C4 Therapeutics (CCCC) management likely cover on December 3, 2025?

Management is expected to discuss the company’s clinical programs and corporate strategy.

Where and when is the 8th Annual Evercore Healthcare Conference taking place?

The conference runs December 2–4, 2025 in Coral Gables, Florida.